A very challenging project started thanks to the wide know how on specific automated machine for cytostatics and antibiotics preparations of our Partner eng. Paolo Giribona (see CV here).
Biovalley Investments S.p.a. firmly believed in the strategical value of this project, becoming its main investor.
Engmotion d.o.o. supported Paolo Giribona and Biovalley in projecting, engineering and manufacture the several prototypes to achieve the final machine.
The machine is going to be fully validated and launched in 2020 and it will be a completely new answer to the market request of a product available for a wide range of Hospitals that are not ready to host big and very expensive Hazardous IV Compounding Robot but would like to gain the benefits of a quite complete automation in preparation processes.